KRYS — Krystal Biotech Share News
0.000.00%
Last trade - 00:00- $9.77bn
- $8.92bn
- $389.13m
Brief: Krystal Biotech Announces First Patient Dosed In Phase 3 Clinical Trial Of Kb803 For The Treatment And Prevention Of Corneal Abrasions
U.S. STOCKS ON THE MOVE-Leidos, Gartner, EVgo
U.S. STOCKS ON THE MOVE-Duke Energy, Leidos, Gartner
Krystal Biotech Inc reports results for the quarter ended March 31 - Earnings Summary
Krystal Biotech falls on Q1 results miss
Brief: Krystal Biotech Q1 Net Income USD 35.733 Million
Brief: Jeune Aesthetics Appoints Marc Forth As Chief Executive Officer
Brief: EMA's CHMP Says Opinion Recommending Marketing Authorisation For Leqembi Not Need To Be Updated
Krystal Biotech rises after quarterly revenue beat
Brief: Krystal Biotech Q4 Net Income USD 45.479 Million
Brief: Krystal Biotech Announces Early Evidence Of Monotherapy Activity In Heavily Pre-Treated Patients With Advanced Non-Small Cell Lung Cancer
Brief: Krystal Biotech Provides Update On EMA’S Ongoing Regulatory Review
Krystal Biotech Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: Krystal Biotech Q3 Net Income USD 27.18 Million
Krystal Biotech Inc reports results for the quarter ended in June - Earnings Summary
Brief: Krystal Biotech Q2 Net Income USD 15.568 Million
Krystal Biotech Inc expected to post earnings of 58 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-GoDaddy, Walt Disney, Aerovironment
U.S. STOCKS ON THE MOVE-NAPCO Security Technologies, Outset Medical, US energy sector